Insmed Incorporated

NasdaqGS:INSM 株式レポート

時価総額:US$13.1b

Insmed 配当と自社株買い

配当金 基準チェック /06

Insmed配当金を支払った記録がありません。

主要情報

n/a

配当利回り

-10.0%

バイバック利回り

総株主利回り-10.0%
将来の配当利回り0%
配当成長n/a
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金n/a
配当性向n/a

最近の配当と自社株買いの更新

更新なし

Recent updates

Insmed: PAH Treatment Advancement With 2nd Half 2025 Top-Line Data

Nov 20

Insmed Incorporated's (NASDAQ:INSM) Share Price Not Quite Adding Up

Sep 12
Insmed Incorporated's (NASDAQ:INSM) Share Price Not Quite Adding Up

Insmed: Brensocatib Propels Stock As Regulatory Milestones Approach

Aug 28

Is Insmed (NASDAQ:INSM) A Risky Investment?

Aug 10
Is Insmed (NASDAQ:INSM) A Risky Investment?

Insmed Incorporated's (NASDAQ:INSM) 92% Share Price Surge Not Quite Adding Up

May 29
Insmed Incorporated's (NASDAQ:INSM) 92% Share Price Surge Not Quite Adding Up

Insmed Strikes Gold With Phase 3 Bronchiectasis Win (Rating Upgrade)

May 28

Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Feb 25
Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected

Dec 18
Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected

Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely

Jul 28
Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely

Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Jul 01
Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?

Apr 18
Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?

A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)

Feb 23
A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)

Insmed inks financing agreements to raise $500M

Oct 19

Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?

Oct 17
Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued

Sep 20
An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued

Insmed rises 16% on better-than-expected Q2 result

Aug 04

決済の安定と成長

配当データの取得

安定した配当: INSMの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。

増加する配当: INSMの配当金が増加しているかどうかを判断するにはデータが不十分です。


配当利回り対市場

Insmed 配当利回り対市場
INSM 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (INSM)n/a
市場下位25% (US)1.4%
市場トップ25% (US)4.2%
業界平均 (Biotechs)2.3%
アナリスト予想 (INSM) (最長3年)0%

注目すべき配当: INSMは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。

高配当: INSMは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。


株主への利益配当

収益カバレッジ: INSMの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。


株主配当金

キャッシュフローカバレッジ: INSMが配当金を報告していないため、配当金の持続可能性を計算できません。


高配当企業の発掘